Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S11] How Will the Development and NDA Activities in Japan Change in View of the Future of AI Translation?

Session Chair(s)

Michio  Tanaka

Michio Tanaka

Executive Officer, Division Vice president, Science & Data Technology Division

AstraZeneca K.K., Japan

Following 2018 Japan annual meeting, the current status of AI translation in the pharmaceutical field will be reviewed. We will discuss how industrygovernment- academia collaboration should be promoted to further improve quality of AI translation, based on the status and issues of quality improvement before and after adaptation in pharmaceutical companies and success cases in other industries.


Kiyoshi  Kinoshita, PhD

R&D Head Club's WGs report: Quality-improvement before and after Adaptation

Kiyoshi Kinoshita, PhD

MSD K.K., Japan

Manager, Regulatory Affairs, Area Japan Development

Toshiyuki  Shigematsu

Key for Success of Machine Translation - How to Perform Post-Edit Effectively

Toshiyuki Shigematsu

Novartis Pharma Co Ltd, Japan

Medical Writer

Yusuke  Asoh

A Case of Company-wide Introduction of AI Translation Technology -Background, Process and Future Prospects

Yusuke Asoh

Daiichi Sankyo Co., Ltd, Japan

Manager, IT Strategy Department

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.